ATE143808T1 - Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung - Google Patents

Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung

Info

Publication number
ATE143808T1
ATE143808T1 AT93915598T AT93915598T ATE143808T1 AT E143808 T1 ATE143808 T1 AT E143808T1 AT 93915598 T AT93915598 T AT 93915598T AT 93915598 T AT93915598 T AT 93915598T AT E143808 T1 ATE143808 T1 AT E143808T1
Authority
AT
Austria
Prior art keywords
protein tyrosine
tyrosine phosphatase
inhibitors
tumor treatment
phosphatase alpha
Prior art date
Application number
AT93915598T
Other languages
English (en)
Inventor
Catherine Jane Pallen
Xin Min Zheng
Yue Wang
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Application granted granted Critical
Publication of ATE143808T1 publication Critical patent/ATE143808T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93915598T 1992-07-10 1993-07-09 Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung ATE143808T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214754A GB9214754D0 (en) 1992-07-10 1992-07-10 Tumour treatment

Publications (1)

Publication Number Publication Date
ATE143808T1 true ATE143808T1 (de) 1996-10-15

Family

ID=10718558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915598T ATE143808T1 (de) 1992-07-10 1993-07-09 Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung

Country Status (5)

Country Link
EP (1) EP0648123B1 (de)
AT (1) ATE143808T1 (de)
DE (1) DE69305348T2 (de)
GB (1) GB9214754D0 (de)
WO (1) WO1994001119A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682905B1 (en) 1990-07-11 2004-01-27 New York University Receptor-type phosphotyrosine phosphatase-alpha
US7108994B2 (en) 1990-07-11 2006-09-19 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5861266A (en) * 1994-02-28 1999-01-19 New York University Treatment of diabetes mellitus and insulin receptor signal transduction
GB9411671D0 (en) * 1994-06-10 1994-08-03 Univ Singapore Tumor diagnosis and prognosis
GB9516059D0 (en) * 1995-08-04 1995-10-04 Medical Res Council Novel genes and proteins
US6818440B2 (en) 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US6039569A (en) * 1997-08-12 2000-03-21 Jeneric/Pentron Incorporated Fiber-reinforced dental structures and method of manufacture thereof
CN102108365A (zh) * 2009-12-29 2011-06-29 上海新号源生物科技有限公司 一组恶性肿瘤中突变PTPα基因及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase
WO1991013989A1 (en) * 1990-03-14 1991-09-19 Washington Research Foundation Methods and compositions for the treatment of malignancies in which a protein kinase is associated
WO1992001050A1 (en) * 1990-07-11 1992-01-23 New York University Novel receptor-type phosphotyrosine phosphatase

Also Published As

Publication number Publication date
EP0648123A1 (de) 1995-04-19
EP0648123B1 (de) 1996-10-09
DE69305348T2 (de) 1997-02-20
WO1994001119A1 (en) 1994-01-20
GB9214754D0 (en) 1992-08-19
DE69305348D1 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
ATE50500T1 (de) Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
BR9805544C1 (pt) Uso de um composto.
FR2657259B1 (de)
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE222769T1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
SE8104625L (sv) Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ID21698A (id) Karboksamida-karboksamida aril bisiklik dan penggunaan terapinya
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
DE68903378D1 (de) Hemmung der zellenadhaesion.
GR3029490T3 (en) Use of leflunomid for the inhibition of tumor necrosis factor alpha.
DE59510240D1 (de) Hochfrequenztherapieeinrichtung zur interstitiellen Thermotherapie von Tumoren
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
NO891703D0 (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
ES2072280T3 (es) Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf).
NO903537D0 (no) Fremgangsmaate og probe for in vitro paavisning av den ringformede partikkel og kreft hos mennesker og dyr.
DE69033810D1 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
NO913995D0 (no) Inhibitorer for dannelse av tumornekrosefaktor samt fremgangsmaate og anvendelse derav
ATE84416T1 (de) Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hyperthrophie.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee